Encompass Health Future Growth
Future criteria checks 3/6
Encompass Health is forecast to grow earnings and revenue by 10% and 8.8% per annum respectively. EPS is expected to grow by 7.3% per annum. Return on equity is forecast to be 21.4% in 3 years.
Key information
10.0%
Earnings growth rate
7.3%
EPS growth rate
Healthcare earnings growth | 23.1% |
Revenue growth rate | 8.8% |
Future return on equity | 21.4% |
Analyst coverage | Good |
Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,321 | 529 | 195 | 999 | 8 |
12/31/2025 | 5,817 | 483 | 300 | 899 | 12 |
12/31/2024 | 5,347 | 437 | 285 | 925 | 10 |
6/30/2024 | 5,071 | 409 | 215 | 872 | N/A |
3/31/2024 | 4,957 | 387 | 239 | 862 | N/A |
12/31/2023 | 4,801 | 362 | 268 | 851 | N/A |
9/30/2023 | 4,692 | 357 | 249 | 822 | N/A |
6/30/2023 | 4,574 | 336 | 97 | 677 | N/A |
3/31/2023 | 4,450 | 280 | 144 | 715 | N/A |
12/31/2022 | 4,349 | 256 | 122 | 706 | N/A |
9/30/2022 | 4,254 | 232 | 81 | 657 | N/A |
6/30/2022 | 4,175 | 242 | 216 | 765 | N/A |
3/31/2022 | 3,844 | 253 | 216 | 776 | N/A |
12/31/2021 | 4,015 | 298 | 170 | 716 | N/A |
9/30/2021 | 4,187 | 316 | 381 | 872 | N/A |
6/30/2021 | 4,350 | 318 | 408 | 868 | N/A |
3/31/2021 | 4,693 | 304 | 410 | 834 | N/A |
12/31/2020 | 3,566 | 193 | 300 | 705 | N/A |
9/30/2020 | 4,614 | 265 | 244 | 641 | N/A |
6/30/2020 | 4,602 | 285 | 169 | 582 | N/A |
3/31/2020 | 4,663 | 342 | 89 | 505 | N/A |
12/31/2019 | 4,605 | 358 | 231 | 635 | N/A |
9/30/2019 | 4,517 | 317 | 238 | 598 | N/A |
6/30/2019 | 4,423 | 308 | 362 | 682 | N/A |
3/31/2019 | 4,355 | 309 | 417 | 706 | N/A |
12/31/2018 | 4,277 | 290 | 486 | 762 | N/A |
9/30/2018 | 4,190 | 339 | 476 | 735 | N/A |
6/30/2018 | 4,104 | 316 | 458 | 712 | N/A |
3/31/2018 | 4,003 | 288 | N/A | 694 | N/A |
12/31/2017 | 3,914 | 271 | N/A | 658 | N/A |
9/30/2017 | 3,841 | 260 | N/A | 642 | N/A |
6/30/2017 | 3,771 | 256 | N/A | 645 | N/A |
3/31/2017 | 3,710 | 256 | N/A | 646 | N/A |
12/31/2016 | 3,643 | 247 | N/A | 640 | N/A |
9/30/2016 | 3,576 | 228 | N/A | 616 | N/A |
6/30/2016 | 3,432 | 217 | N/A | 602 | N/A |
3/31/2016 | 3,280 | 198 | N/A | 552 | N/A |
12/31/2015 | 3,116 | 181 | N/A | 502 | N/A |
9/30/2015 | 2,857 | 173 | N/A | 438 | N/A |
6/30/2015 | 2,678 | 172 | N/A | 415 | N/A |
3/31/2015 | 2,520 | 204 | N/A | 440 | N/A |
12/31/2014 | 2,374 | 208 | N/A | 445 | N/A |
9/30/2014 | 2,336 | 144 | N/A | 476 | N/A |
6/30/2014 | 2,303 | 148 | N/A | 479 | N/A |
3/31/2014 | 2,266 | 228 | N/A | 456 | N/A |
12/31/2013 | 2,247 | 229 | N/A | 470 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HSOA's forecast earnings growth (10% per year) is above the savings rate (0.8%).
Earnings vs Market: HSOA's earnings (10% per year) are forecast to grow slower than the German market (20.2% per year).
High Growth Earnings: HSOA's earnings are forecast to grow, but not significantly.
Revenue vs Market: HSOA's revenue (8.8% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: HSOA's revenue (8.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HSOA's Return on Equity is forecast to be high in 3 years time (21.4%)